Susquehanna International Group, LLP Navidea Biopharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.08 - $0.29 $10,069 - $36,501	125,866 New	125,866 $11,000
Q3 2021 Nov 15, 2021	BUY	$1.53 - $1.85 $2,314 - $2,799	1,513 Added 3.61%	43,445 $76,000
Q2 2021 Aug 11, 2021	BUY	$1.55 - $2.15 $45,903 - $63,672	29,615 Added 240.44%	41,932 $77,000
Q1 2021 May 17, 2021	SELL	$1.99 - $2.9 $2,131 - $3,105	-1,071 Reduced 8.0%	12,317 $25,000
Q4 2020 Feb 16, 2021	SELL	$1.88 - $2.84 $63,042 - $95,233	-33,533 Reduced 71.47%	13,388 $29,000
Q2 2020 Aug 14, 2020	BUY	$0.7 - $4.16 $32,844 - $195,191	46,921 New	46,921 $185,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.